References
- Myles PR, Semple MG, Lim WS, Openshaw PJM, Gadd EM, Read RC, Taylor BL, Brett SJ, McMenamin J, Enstone JE, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax. 2012;67(8):709–717. doi:https://doi.org/10.1136/thoraxjnl-2011-200266.
- Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PAB, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12(9):1023–1026. doi:https://doi.org/10.1038/nm1462.
- Johnston SL. Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Allergy. 2020;75(7):1543–1545. doi:https://doi.org/10.1111/all.14348.
- Beurnier A, Jutant E-M, Jevnikar M, Boucly A, Pichon J, Preda M, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020;56(5) :2001875. doi:https://doi.org/10.1183/13993003.01875-2020.
- Kaeuffer C, Le Hyaric C, Fabacher T, Mootien J, Dervieux B, Ruch Y, et al. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Euro Surveill. 2020;25(48) :2000895. doi:https://doi.org/10.2807/1560-7917.ES.2020.25.48.2000895.
- Caminati M, Vultaggio A, Matucci A, Senna G, Almerigogna F, Bagnasco D, et al. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2020;176:106261.
- Grandbastien M, Piotin A, Godet J, Abessolo-Amougou I, Ederlé C, Enache I, Fraisse P, Tu Hoang TC, Kassegne L, Labani A, et al. SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. J Allergy Clin Immunol Pract. 2020;8(8):2600–2607. doi:https://doi.org/10.1016/j.jaip.2020.06.032.
- Hanon S, Brusselle G, Deschampheleire M, Louis R, Michils A, Peché R, Pilette C, Rummens P, Schuermans D, Simonis H, et al. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020;56(6):2002857. doi:https://doi.org/10.1183/13993003.02857-2020.
- Rial MJ, Valverde M, Del Pozo V, González-Barcala FJ, Martínez-Rivera C, Muñoz X, et al. Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak. J Allergy Clin Immunol Pract. 2021;9(1):487–489.e1. doi:https://doi.org/10.1016/j.jaip.2020.09.050.
- Robinson LB, Fu X, Bassett IV, Triant VA, Foulkes AS, Zhang Y, et al. COVID-19 severity in hospitalized patients with asthma: A matched cohort study. J Allergy Clin Immunol Pract. 2021;9(1):497–500. doi:https://doi.org/10.1016/j.jaip.2020.10.021.
- Hussein MH, Toraih EA, Attia AS, Burley N, Zhang AD, Roos J, Houghton A, Aniemeka N, Omar M, Aboueisha M, et al. Asthma in COVID-19 patients: An extra chain fitting around the neck? Respir Med. 2020;175:106205. doi:https://doi.org/10.1016/j.rmed.2020.106205.
- Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021. doi:https://doi.org/10.1016/S2213-2600(21)00013-8.
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–793. doi:https://doi.org/10.1001/jama.2020.12839.
- Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. doi:https://doi.org/10.1183/13993003.01009-2020.
- Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G, et al. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021; 9(3):1152–1162.e3. doi:https://doi.org/10.1016/j.jaip.2020.12.045.
- Bradding P, Richardson M, Hinks TSC, Howarth PH, Choy DF, Arron JR, Wenzel SE, Siddiqui S. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19. J Allergy Clin Immunol. 2020;146(1):208–211. doi:https://doi.org/10.1016/j.jaci.2020.05.013.
- Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, et al. Association of respiratory allergy, asthma and expression of the SARS-CoV-2 receptor, ACE2. J Allergy Clin Immunol. 2020; 146(1):203–206.e3. doi:https://doi.org/10.1016/j.jaci.2020.04.009.
- Farne H, Singanayagam A. Why asthma might surprisingly protect against poor outcomes in COVID-19. Eur Respir J. 2020;56(6):2003045. doi:https://doi.org/10.1183/13993003.03045-2020.
- Gupta A, Bush A, Nagakumar P. Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management. Lancet Respir Med. 2020;8(11):1070–1071. doi:https://doi.org/10.1016/S2213-2600(20)30278-2.
- Conseil de Santé Publique H. Coronavirus SARS-CoV-2 prise en charge des personnes à risque de formes graves. 2020; Sect. https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=790.
- Tran V-T, Ravaud P. COllaborative open platform E-cohorts for research acceleration in trials and epidemiology. J Clin Epidemiol. 2020;124:139–148. doi:https://doi.org/10.1016/j.jclinepi.2020.04.021.
- Potier L, Hansel B, Larger E, Gautier J-F, Carreira D, Assemien R, et al. Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes. Diabetes Care. 2021;44(3):839–843. doi: https://doi.org/10.2337/dc20-2019.
- Cénat JM, Blais-Rochette C, Kokou-Kpolou CK, Noorishad P-G, Mukunzi JN, McIntee S-E, Dalexis RD, Goulet M-A, Labelle PR. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2021;295:113599. doi:https://doi.org/10.1016/j.psychres.2020.113599.
- Picchianti DA, Cattaruzza MS, Di Rosa R, Del Porto F, Salemi S, Sorgi ML, et al. Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in Italy. Microorganisms. 2020;8(11):1818. doi:https://doi.org/10.3390/microorganisms8111818.
- Mahil SK, Yates M, Langan SM, Yiu ZZN, Tsakok T, Dand N, et al. Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. Br J Dermatol. 2020. doi:https://doi.org/10.1111/bjd.19755.
- Lupia T, Scabini S, Mornese PS, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020;21:22–‑27. doi:https://doi.org/10.1016/j.jgar.2020.02.021.
- Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, Akdis CA, Gao Y-d. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:https://doi.org/10.1111/all.14238.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:https://doi.org/10.1001/jama.2020.1585.
- Siewe Fodjo JN, Villela E. F d M, Van Hees S, Dos Santos TT, Vanholder P, Reyntiens P, Van den Bergh R, Colebunders R. Impact of the COVID-19 Pandemic on the Medical Follow-up and Psychosocial Well-Being of People Living With HIV: A Cross-Sectional Survey. J Acquir Immune Defic Syndr. 2020;85(3):257–262. doi:https://doi.org/10.1097/QAI.0000000000002468.
- Marijon E, Karam N, Jost D, Perrot D, Frattini B, Derkenne C, Sharifzadehgan A, Waldmann V, Beganton F, Narayanan K, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study. Lancet Public Health. 2020;5(8):e437–e443. doi:https://doi.org/10.1016/S2468-2667(20)30117-1.